By Debdeep Gupta | 12 Dec, 2024
Gland Pharma shares gain 2% on USFDA approval for Phytonadione injectable emulsion
Gland Pharma's share price rose 2 percent in the opening trade on December 12 after the company received approval from the United States Food and Drug Administration (USFDA) for Phytonadione Injectable Emulsion USP, 10 mg/mL single-dose ampules.At 09:21 am, Gland Pharma was quoting at Rs 1,823.70, up Rs 48.35, or 2.72 percent, on the BSE.The product is bioequivalent and therapeutically equivalent ...
Live Comments